In order to help Ukrainian patients, the Southampton Medicines Advice Service have compiled a list of useful resources which we are grateful to be able to share: The International Pharmacy Federation (FIP) has produced...
The National Antiviral Service (NAVS) has two new pages on this site. Information for members of the public can be found at Healthcare professionals can access additional information to assist their clinical decisions at
The new national COVID-19 treatment Patient Group Directions (PGDs) for casirivimab and imdevimab, sotrovimab, and molnupiravir are now available for adaptation by NHS Wales Local Health Boards. You can access these via our Publications...
Medication Safety Officer (MSO) – Cardiff and Vale UHB Hi, I’ve been asked to share with you my experience in the role of Medication Safety Officer (MSO) – a part of my job I...
There is a new patient information leaflet in Welsh on tocilizumab treatment of COVID-19.
New Q&A – Is there a role for inhaled epoprostenol, inhaled nitric oxide or sildenafil to treat secondary pulmonary hypertension and hypoxaemia in ICU patients with acute respiratory distress syndrome?
There is a new UKMi Q&A – Is there a role for inhaled epoprostenol, inhaled nitric oxide or sildenafil to treat secondary pulmonary hypertension and hypoxaemia in ICU patients with acute respiratory distress syndrome?
To aid in the appropriate use of medicines during the current Coronavirus (COVID-19) pandemic, AWTTC have provided therapeutic advice for information on the AWTTC.org website.
There is an update to the UKMi Q&A: How should crusted and other forms of difficult-to-treat scabies be managed?
There is an update to the UKMi Q&A for Which commonly used nebuliser solutions are compatible?
There is an updated UKMi Q&A: Cannabidiol-oil-potential-adverse-effects